Our UAE team contribute to the 8th edition of the Life Sciences Law Review

The eighth edition of The Life Sciences Law Review covers a total of 33 jurisdictions, providing an overview of legal requirements of interest to pharmaceutical, biotechnology and medical device companies. The chapters are arranged so as to describe requirements throughout the life cycle of a regulated product, from discovery to clinical trials, the marketing authorisation process and post-approval controls.

Partner, Melissa Murray and Senior Associate, Surabhi Singhi provided content for the regulatory framework in the life sciences sector in the United Arab Emirates.

Click here for the review >

This article was first published by Law Business Research Ltd in April 2020.

Latest insights

More Insights
cards

Gambling Commission Announces New Changes

May 03 2024

Read More
Birds on a beach

Australia to fast-track some privacy & e-safety reforms to bolster individual rights and combat doxxing

May 03 2024

Read More
gambling

The House Calls for the Government to Double Down on Gambling Advertising Regulation

May 02 2024

Read More

Related capabilities